Printer Friendly

Eon Labs Introduces First Generic Approval to Market With Bisoprolol Fumarate Tablets.

Health & Business Editors

LAURELTON, N.Y.--(BW HealthWire)--Nov. 17, 2000

Eon Labs has introduced Bisoprolol Fumarate, 5mg and 10mg Tablets, the first generic approval to market that is proven to be bioequivalent to the brand Zebeta(R)(1). Sales for the antihypertensive jumped by 68% in the past 12 months as demand has increased(2).

"The introduction of Bisoprolol Fumarate, our third exclusive generic thus far this year, is part of Eon's strategy to be first to market with niche, as well as blockbuster generics", said Frank Della Fera, Vice President of Sales and Marketing for Eon Labs. "Bisoprolol Fumarate is one of many new approvals for Eon Labs as we continue to be one of the most prolific marketers of new ANDA's in the generic industry", concluded Della Fera.

Eon Labs is one of the leading generic pharmaceutical companies in the U.S., widely known as the "Pharmacy Drug Company." For more information on Eon Bisoprolol Fumarate, or other quality products from Eon Labs, call 1-800-526-0225, or write to Eon Labs Manufacturing, Inc., 227-15 N. Conduit Avenue, Laurelton, N.Y., 11413.

Product photo available upon request.

(1) Zebeta is a registered trademark of Lederle Laboratories and is

not affiliated with Eon Labs Manufacturing, Inc.

(2) Source: Scott-Levin, SPA September 2000.
COPYRIGHT 2000 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2000, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Geographic Code:1USA
Date:Nov 17, 2000
Previous Article:Vingage Selected by Siscom as Technology Partner for Management and Delivery of Video Over the Internet.
Next Chairman and CEO Appears on GPTV Georgia Business Report.

Related Articles
Faulding Receives USA FDA Tentative Approval for Bisoprolol Fumerate and Hydrochlorothiazide Tablets 2.5 mg / 6.25 mg, 5 mg / 6.25 mg and 10 mg /...
Faulding Receives USA FDA Final Approval for Bisoprolol Fumerate and Hydrochlorothiazide Tablets.
Eon Labs Introduces Alternative for $300 Million Brand On First Day of Generic Availability.
Mylan Receives Approval on Bisoprolol Fumarate and Hydrochlorothiazide Tablets.
IVAX Receives Final Approval for Bisoprolol Fumarate and Hydrochlorothiazide Tablets.
Eon Labs First to Commercialize Generic Fluvoxamine Maleate Tablets.
Tenofovir: FDA Hearing October 3, Public Comment Deadlines September 26.
Tenofovir approved: Broad indication.

Terms of use | Privacy policy | Copyright © 2019 Farlex, Inc. | Feedback | For webmasters